My watch list
my.bionity.com  
Login  

TopoTarget (OMX: TOPO) is a biotech company dedicated to finding "Answers for cancer". The Company is focused on the development and commercialisation of improved treatments for cancer patients, and other cancer-related disorders. TopoTarget has a marketed product in both Europe and the US and a broad late stage clinical pipeline containing nine products.

TopoTarget was formed in 2000 in Copenhagen, and is headquartered in Denmark with subsidiaries in the US, Switzerland, Germany and the UK. The company completed a successful IPO on the OMX Nordic Exchange in Copenhagen in 2005. TopoTarget was founded and is run by clinical cancer specialists, and combines years of hands-on clinical experience with an in-depth understanding of the molecular mechanisms of cancer.

More about TopoTarget
  • News

    SpePharm announces the acquisition of Savene from TopoTarget

    SpePharm Holding, BV announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S. As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget ... more

    TopoTarget announces new CEO to prepare commercialisation of belinostat

    TopoTarget A/S announced that Francois Martelet, MD, takes up the position of CEO of TopoTarget in order to add the necessary late-stage clinical development and marketing expertise to ensure a successful development and commercialisation of belinostat, TopoTarget's lead anticancer drug. ... more

    TopoTarget completes the capital increase and the acquisition of Apoxis SA

    TopoTarget A/S announced the completion of the acquisition of Apoxis SA with 3,598,030 shares having been issued to the vendors of Apoxis. Hereby TopoTarget gains two oncology products to its pipeline. Consistent with the growth strategy pursued by TopoTarget, the acquisition of the Swiss b ... more

  • Companies

    TopoTarget Germany AG

    TopoTarget is a dynamic international biotech company dedicated to finding "Answers for cancer". Founded by clinicians with a thorough knowledge of the molecular mechanisms of cancer, our goal is to find and develop cancer therapies, bringing them to the market to benefit patients. As wel ... more

    TopoTarget Switzerland S.A.

    TopoTarget is a dynamic international biotech company dedicated to finding "Answers for cancer". Founded by clinicians with a thorough knowledge of the molecular mechanisms of cancer, our goal is to find and develop cancer therapies, bringing them to the market to benefit patients. As wel ... more

    TopoTarget USA, Inc.

    TopoTarget is a dynamic international biotech company dedicated to finding "Answers for cancer". Founded by clinicians with a thorough knowledge of the molecular mechanisms of cancer, our goal is to find and develop cancer therapies, bringing them to the market to benefit patients. As wel ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE